{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-000937","form_type":"8-K","ticker":"AMIX","cik":"0001617867","company_name":"Autonomix Medical, Inc.","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.652902+00:00","generated_at":"2026-05-16T11:03:48.983821+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Autonomix reports pancreatic cancer pain relief across all stages in PoC study at ASCO GI 2026","bullets":["Rapid pain reduction within 24 hours of transvascular RF denervation procedure.","At 7 days, 93.75% of responding patients (N=16) improved from severe to mild/moderate pain.","At 4-6 weeks, ~2/3 of responders (N=9) maintained mild or eliminated pain levels.","At 3 months, no responders (N=6) had severe pain; 50% maintained mild or eliminated pain.","Even late-stage (Stage 4) patients showed meaningful early improvement despite disease progression."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-000937","json":"https://secwatch.observer/filing/0001437749-26-000937.json","markdown":"https://secwatch.observer/filing/0001437749-26-000937.md","text":"https://secwatch.observer/filing/0001437749-26-000937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926000937/0001437749-26-000937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926000937/amix20260108_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:03:48.983821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}